Variant report
Variant | nsv1043984 |
---|---|
Chromosome Location | chr10:55436702-55457884 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554411104 | chr10:55437816-55437817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189683560 | chr10:55437850-55437851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs180907049 | chr10:55437852-55437853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547285974 | chr10:55437928-55437929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567022784 | chr10:55437935-55437936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553061963 | chr10:55437939-55437940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146346397 | chr10:55437943-55437944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76101037 | chr10:55437975-55437976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186320317 | chr10:55437979-55437980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75837804 | chr10:55438029-55438030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544594516 | chr10:55438037-55438038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561536264 | chr10:55438062-55438063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529715462 | chr10:55438098-55438099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540192912 | chr10:55438120-55438121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538338292 | chr10:55438124-55438125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560179299 | chr10:55438157-55438158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532151833 | chr10:55438250-55438251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35367570 | chr10:55438254-55438255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558235739 | chr10:55438258-55438259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370144736 | chr10:55438280-55438281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114080624 | chr10:55438284-55438285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs578077381 | chr10:55438288-55438289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139301614 | chr10:55438326-55438327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531508520 | chr10:55438356-55438357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375713186 | chr10:55438368-55438369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567976355 | chr10:55438374-55438375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs16937642 | chr10:55438386-55438387 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs552998433 | chr10:55438389-55438390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566836890 | chr10:55438418-55438419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191565012 | chr10:55438419-55438420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558974812 | chr10:55438429-55438430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149511934 | chr10:55438434-55438435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs825805 | chr10:55438490-55438491 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs572907825 | chr10:55438645-55438646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs825806 | chr10:55438682-55438683 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs540922785 | chr10:55438685-55438686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs35167625 | chr10:55438706-55438707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559917640 | chr10:55438785-55438786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs17697085 | chr10:55438823-55438824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115093226 | chr10:55438848-55438849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562559865 | chr10:55438865-55438866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144829074 | chr10:55438960-55438961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186198000 | chr10:55442207-55442208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141444782 | chr10:55442245-55442246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575906655 | chr10:55442254-55442255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528775016 | chr10:55442417-55442418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538477460 | chr10:55442471-55442472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189261396 | chr10:55442477-55442478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563698524 | chr10:55442481-55442482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111424928 | chr10:55442482-55442483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Melanoma | 17363583 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:55437800-55438400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr10:55437800-55438600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr10:55437800-55439000 | Enhancers | Fetal Lung | lung |
4 | chr10:55438000-55438400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr10:55438200-55438600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr10:55442200-55443400 | Enhancers | Fetal Brain Male | brain |
7 | chr10:55442400-55442800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr10:55449200-55449600 | Enhancers | Right Atrium | heart |
9 | chr10:55449400-55454200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr10:55449600-55450000 | Weak transcription | Right Atrium | heart |
11 | chr10:55450000-55450600 | Enhancers | Right Atrium | heart |
12 | chr10:55450200-55450600 | Enhancers | Sigmoid Colon | Sigmoid Colon |
13 | chr10:55450200-55451000 | Enhancers | Fetal Heart | heart |
14 | chr10:55454200-55454400 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr10:55454200-55454400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr10:55454400-55454600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |